Innovating Works

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ

Activa
CURE HEARTandBRAIN: CURE HEARTandBRAIN postdoctoral COFUND programme by CNIC CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-COFUND-01-01 The CNIC (Spanish Centre for Cardiovascular Research) is a worldwide recognised research centre dedicated to cardiovascular research. CNIC’s...
2023-09-19 - 2028-12-31 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: SC1-BHC-08-2020 The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer su...
2021-01-29 - 2026-05-31 | Financiado
RITA-MI 2: Rituximab in patients with acute myocardial infarction a phase 2 placebo controlled randomised clin... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un H2020: SC1-BHC-08-2020 RITA-MI 2 will assess the impact of a novel therapeutic strategy targeting patients’ immune response on the recovery of heart function after...
2021-01-18 - 2026-05-31 | Financiado
unCoVer: Unravelling Data for Rapid Evidence Based Response to COVID 19 INSTITUUT VOOR TROPISCHE GENEESKUNDE tramitó un H2020: SC1-PHE-CORONAVIRUS-2020-2E UnCoVer is a functional network of research institutions collecting data derived from the provision of care to COVID-19 patients by health s...
2020-10-30 - 2023-05-14 | Financiado
AMELIE: Anchored Muscle cELls for IncontinencE UNIVERSITY COLLEGE LONDON tramitó un H2020: SC1-BHC-07-2019 Faecal incontinence (FI) is a common condition affecting ~67 million people in Europe, seriously impairing living and productivity of affect...
2020-05-06 - 2025-08-31 | Financiado
PRECISMEDLYM: Aggressive T cell Lymphomas integrated clinical and genomic analysis for a precision medicine. FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un H2020: MSCA-IF-2019 Lymphoid leukemias and lymphomas represent frequent areas of the tumour pathology. Recent Integrative clinical and molecular studies allows...
2020-03-17 - 2022-09-27 | Financiado
STRATEGY-CKD: System omics to unravel the gut kidney axis in Chronic Kidney Disease. UNIVERSITEIT GENT tramitó un H2020: MSCA-ITN-2019 System omics to unravel the gut-kidney axis in Chronic Kidney Disease: There is a great need for multi-disciplinary and methodologically wel...
2020-02-05 - 2024-07-31 | Financiado
PROFID: Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardi... CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un H2020: SC1-BHC-25-2019 Sudden cardiac death (SCD) is a major public health problem accounting for ~20% of all deaths in Europe with an estimated yearly incidence o...
2019-12-13 - 2024-12-31 | Financiado
MATRIX: Novel mitochondria targeted therapies for cancer treatment induced cardiotoxicity CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: ERC-2018-COG Cardiac toxicity is one of the most frequent serious side effects of cancer therapy, affecting up to 30% of treated patients. Cancer treatme...
2019-04-29 - 2025-05-31 | Financiado
SELNET: Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Lati... FUNDACION INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ tramitó un H2020: SC1-BHC-18-2018 Rare cancersRare cancers are associated with poor survival, accounting for 22% of new cancer diagnoses in Europe, and 30% of cancer deaths....
2018-12-14 - 2023-12-31 | Financiado
UshTher: Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher... FONDAZIONE TELETHON ETS tramitó un H2020: SC1-PM-08-2017 Usher syndrome (USH) is the most common combination of deafness and blindness due to retinitis pigmentosa. USHIB caused by mutations in th...
2017-11-27 - 2023-06-30 | Financiado
CaReSyAn: Combatting the CardioRenal Syndrome towards an integrative Analysis to reduce cardiovascular burden... UNIVERSITAETSKLINIKUM AACHEN tramitó un H2020: MSCA-ITN-2017 Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accompli...
2017-08-10 - 2021-12-31 | Financiado
NanoSmell: NanoSmells Artificial remote controlled odorants WEIZMANN INSTITUTE OF SCIENCE tramitó un H2020: FETOPEN-RIA-2014-2015 "Despite years of promise, an odor-emitting component in devices such as televisions, phones, computers and more has yet to be developed. Tw...
2015-05-27 - 2019-08-31 | Financiado
E-PREDICE: Early Prevention of Diabetes Complications in people with Hyperglycaemia in Europe "Background: A significant proportion of pre-diabetics, show macro and micro vascular complications associated with hyperglycaemia. Although...
Financiado
PRESBYOPIA: Bio inspired optical corrections of presbyopia AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS tramitó un FP7: The human crystalline lens has the capability to dynamically change its shape to focus near and far objects. By age 55, the accommodation ca...
Financiado
EUROGENTEST2: Genetic testing in Europe Network for the further development harmonization validation and stand... KATHOLIEKE UNIVERSITEIT LEUVEN tramitó un FP7: EuroGentest is an FP6 European network for the harmonization of genetic testing and for the further improvement of quality in genetic servic...
Financiado
PRIORITY: Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabeti... REGION HOVEDSTADEN tramitó un FP7: Patients with diabetes are at risk of developing diabetic nephropathy, which will ultimately result in the requirement for renal replacement...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.